Asymmetric synthesis of highly functionalized lactones and lactams using a chiral Bronsted acid
使用手性布朗斯台德酸不对称合成高官能化内酯和内酰胺
基本信息
- 批准号:8958040
- 负责人:
- 金额:$ 34.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-01 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:1-Propanol3-DimensionalAcidsAlcoholsApplications GrantsBINOLBiochemistryBiological FactorsBiological TestingBiologyCatalysisChemistryCollaborationsComplexCongenital AbnormalityCyclizationDataDevelopmentEstersEthanolFutureGeometryGoalsHandednessHealthHousingHydroxyl RadicalIonsKineticsLaboratoriesLaboratory ResearchLactamsLactonesLeadLibrariesMediatingMedicineMethodologyMethodsMolecularMolecular and Cellular BiologyNatural Products ChemistryNatureNauseaPaperPharmaceutical PreparationsPharmacologic SubstancePhosphoric AcidsPreparationProcessPropertyProtonsPublishingReactionResearchResearch PersonnelResolutionShapesStructureStudentsSulfonamidesVariantWorkantimicrobialbasebeta-Lactamscatalystconformercytotoxiccytotoxicitydrug discoveryenantiomerexperiencegraduate studentinnovationnovelnovel strategiesprocess repeatabilityracemizationresearch studyscaffoldsmall moleculesmall molecule librariesundergraduate research
项目摘要
DESCRIPTION (provided by applicant): The development of new synthetic methods in order to synthesize the vast array of structurally diverse compounds that nature produces only in small quantities or to efficiently prepare libraries of small molecules for drug discovery is a constant need in chemistry. This proposal outlines two novel strategies for the synthesis of enantioenriched
α,α-disubstituted lactones and lactams that take advantage of the different rates of cyclization of prochiral or racemic compounds in the presence of a chiral Brønsted acid catalyst The first goal of the project (Aim 1) is the development of a chiral Brønsted acid catalyzed desymmetrization of amino or hydroxyl diesters. In this aim, α,α-disubstituted lactones will be prepared through the development of a desymmetrization of prochiral hydroxy esters. This will be followed by the expansion of the desymmetrization process to include protected amino diesters to yield α,α-disubstituted lactams. The second objective of the proposal (Aim 2) is the establishment of a chiral Brønsted acid mediated dynamic kinetic resolution. Here, the rapid racemization of the two enantiomers of a racemic mixture in combination with the preferred cyclization of an enantiomer of the racemic mixture will funnel the reaction to the formation of a single cyclic product. The DKR explored will utilize an oxocarbenium ion intermediate. The third goal (Aim 3) of the project is the application of asymmetric methodologies to the formation of novel heterocyclic cores. In this section, the synthetic methods developed will be utilized in the formation of libraries of novel heterocyclic scaffolds such as spirocycles and new beta-lactam scaffolds with potentially potent antimicrobial or cytotoxic properties.
描述(由应用提供):开发新的合成方法,以综合大自然仅少量产生的各种结构多样的化合物,或有效地准备小分子的库来发现药物发现是化学中持续需求的。该提议概述了对映体合成的两种新型策略
在存在手性BrønstedAcid的情况下,利用α,α-脱取代的内酯和乳糖,利用了手术或外消旋化合物的不同速率,是该项目的第一个目标(AIM 1)是手势Brønsted酸催化了对氨基化的手势促进了对Amino或hysrys的抗体化。在此目的中,将通过开发对治疗羟基酯的去对称性化来制备α,α-二取代的内酯。随后将扩展去对称过程,以包括受保护的氨基二极管,以产生α,α-二取代的乳糖。该提案的第二个目标(AIM 2)是建立手性BrønstedAcid介导的动态动力学分辨率。在这里,外消旋混合物的两个对映异构体的快速种族化结合了对映异构体的首选循环化,这将使对单个环状产物形成的反应将反应引向反应。探索的DKR将利用氧化碳离子中间体。该项目的第三个目标(AIM 3)是将不对称方法应用于新型异环核的形成。在本节中,开发的合成方法将用于形成具有潜在潜在潜在抗菌或细胞毒性特性的新型杂环支架和新的β-内酰胺支架。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nonenzymatic enantioselective synthesis of all-carbon quaternary centers through desymmetrization.
- DOI:10.1016/j.tetlet.2015.09.134
- 发表时间:2015-11-25
- 期刊:
- 影响因子:1.8
- 作者:Petersen KS
- 通讯作者:Petersen KS
Chiral Brønsted Acid Catalyzed Kinetic Resolutions.
- DOI:10.1002/ajoc.201600021
- 发表时间:2016-03
- 期刊:
- 影响因子:2.7
- 作者:Petersen, Kimberly S.
- 通讯作者:Petersen, Kimberly S.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kimberly Sue Petersen其他文献
Kimberly Sue Petersen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kimberly Sue Petersen', 18)}}的其他基金
Stereoselective Synthesis of Biologically Relevant Heterocycles via Brønsted Acid Catalysis
通过布伦斯台德酸催化立体选择性合成生物相关杂环
- 批准号:
10202815 - 财政年份:2021
- 资助金额:
$ 34.11万 - 项目类别:
相似国自然基金
单一取向CsPbBr3一维光波导阵列在异质半导体低维结构上的面内集成及其在光电互联中的应用研究
- 批准号:62374057
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
磁场-电场协同作用下LaAlO3/SrTiO3界面二维电子气的圆偏振光伏效应研究
- 批准号:12304222
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Sirtuin 3维持平滑肌细胞线粒体呼吸功能抑制A型主动脉夹层发病的作用和机制
- 批准号:82300538
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
应变调控二维磁性材料VX3的磁光拉曼研究
- 批准号:12304042
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
cohesin与SYCP3协同调控精母细胞减数分裂联会复合体形成过程中染色质三维结构建立的分子机制
- 批准号:32370574
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Microbiome targeted oral butyrate therapy in Gulf War multisymptom illness
微生物组靶向口服丁酸盐治疗海湾战争多症状疾病
- 批准号:
10367805 - 财政年份:2023
- 资助金额:
$ 34.11万 - 项目类别:
Pharmacokinetics-Based DNA-Encoded Library Screening
基于药代动力学的 DNA 编码文库筛选
- 批准号:
10644211 - 财政年份:2023
- 资助金额:
$ 34.11万 - 项目类别:
Genome Instability Induced Anti-Tumor Immune Responses
基因组不稳定性诱导的抗肿瘤免疫反应
- 批准号:
10626281 - 财政年份:2023
- 资助金额:
$ 34.11万 - 项目类别:
Engineered tissue arrays to streamline deimmunized DMD gene therapy vectors
工程组织阵列可简化去免疫 DMD 基因治疗载体
- 批准号:
10724882 - 财政年份:2023
- 资助金额:
$ 34.11万 - 项目类别:
Spatio-temporal mechanistic modeling of whole-cell tumor metabolism
全细胞肿瘤代谢的时空机制模型
- 批准号:
10645919 - 财政年份:2023
- 资助金额:
$ 34.11万 - 项目类别: